Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEMPOUR: Tamsulosin for Post-operative Urinary Retention
NCT03314025Phase 2Unknown
- Sponsor
- CHU de Québec-Université Laval
- Start
- Oct 2017
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tamsulosin in postoperative urinary retention (POUR), sponsored by CHU de Québec-Université Laval. Status: unknown.
02
Drugs
tamsulosin
03
Conditions
postoperative urinary retention (POUR)
Beyond the preview
Go deeper on NCT03314025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03314025.